Disruption of integrin-extracellular matrix interactions in normal epithelial cells induces apoptosis, a process termed anoikis. Reduced sensitivity to anoikis appears to be an important hallmark of oncogenic transformation, particularly in the process of metastasis. Several pathways have been implicated in the suppression of anoikis, however, the events which take place proximal to the integrin receptors remain unclear. Integrin-linked kinase (ILK) is an integrin-interacting protein kinase which has been identi®ed as a potential PDK-2, as it is capable of phosphorylating PKB/Akt on Ser-473, and stimulating its activity. Here, we show that ILK activity is stimulated upon adhesion of SCP2 mouse mammary epithelial cells to ®bronectin, and inhibited in suspended cells. Overexpression of ILK in the anoikis-sensitive SCP2 cells results in a profound inhibition of anoikis, as determined by annexin V binding and activation of caspases 8 and 3. This eect is reversible by the transfection and expression of a dominant-negative, kinase de®cient ILK (ILK KD), as well as by a dominant negative PKB/Akt (PKB AAA). On the other hand, transfection of a dominant negative form of FAK (FRNK) failed to reverse the suppression of anoikis by ILK. Furthermore, inhibition of ILK activity induced anoikis in two anoikis-resistant human breast cancer cell lines. These ®ndings suggest that ILK plays a major role in the suppression of anoikis. Oncogene (2000) 19, 3811 ± 3815.
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Keywords: apoptosis; protein kinase B; ®bronectin; caspases Normal epithelial cells depend upon interactions between integrins and the extracellular matrix for survival, and the loss of this interaction induces apoptosis. This type of suspension-induced apoptosis is termed anoikis (Frisch and Francis, 1994; Frisch and Ruoslahti, 1997) . Anoikis plays an important role in the development of normal tissues, and also appears to block the growth of detached cells at inappropriate locations, thus acting as an important safeguard against oncogenesis. In fact, reduced sensitivity to anoikis appears to be an important hallmark of oncogenesis, particularly in the processes of metastasis (Ruoslahti and Reed, 1994) .
Attached epithelial cells maintain growth and viability through the activation of survival signalling pathways, such as the MAP Kinase pathway and the protein kinase B (PKB)/Akt pathway (Kumar, 1998; Downward, 1998) . It is likely that in the absence of this signal (when cells become detached and integrins are no longer ligated), these survival pathways are no longer activated, and`default' apoptotic pathways are initiated. However, during oncogenic transformation, the activation of certain oncogenes and the loss of tumour suppressor genes can cause the constitutive activation of these pathways, resulting in anchorageindependent growth. Several signalling pathways have been implicated in the suppression of anoikis, including the PKB/Akt survival pathway, and the inhibition of the proapoptotic Fas-associated death domain protein (FADD)/Caspase-8, and jun kinase pathways (Khwaja et al., 1997; Rytomaa et al., 1999; Frisch, 1999; Frisch et al., 1996a) . However, the initiating events in these pathways (those most proximal to the integrin receptors) remain unclear. PKB/Akt inhibits apoptosis by phosphorylating and inactivating apoptotic factors such as Bad and caspase-9 (Datta et al., 1997; Kops et al., 1999) . As well, PKB/Akt modulates the activity of transcription factors, activating NF-kB and phosphorylating and inhibiting the forkhead transcription factor FKHRL1, thus preventing Fas ligand transcription (Romashkova and Makarov, 1999; Brunet et al., 1999) . PKB/Akt activity is regulated in a complex manner through its phosphorylation on Thr-308 and Ser-473 (Downward, 1998) . PDK-1 has been shown to phosphorylate Thr-308 in a phosphatidylinositol-and phosphatidylinositol 3-kinase (PI3-kinase)-dependent manner. Although it was previously reported that PDK-1 may phosphorylate on both sites (Balendran et al., 1999) , it is now clear that a distinct PDK-2 phosphorylates PKB on Ser-473, as this site is still inducibly phosphorylated in PDK-1-null ES cells (Williams et al., 2000) .
Integrin-linked kinase (ILK) (Hannigan et al., 1996) has been identi®ed as a potential PDK-2, since it is capable of regulating PKB/Akt Ser-473 phosphorylation, and inhibition of ILK in PTEN-negative tumour cell lines results in profound inhibition of PKB/Akt Ser-473 phosphorylation and activity (Delcommenne et al., 1998; Lynch et al., 1999; Morimoto et al., 2000; Persad et al., 2000) . ILK is an ankyrin repeatcontaining serine/threonine protein kinase which interacts with the cytoplasmic domains of integrin b1 and b3 cytoplasmic domains. ILK activity can be stimu-lated by both matrix attachment and growth factor stimulation in a phosphatidylinositol-and PI3-kinasedependent manner (Radeva et al., 1997; Delcommenne et al., 1998; Troussard et al., 1999) . As well as its phosphorylation of PKB/Akt, ILK is also able to induce the phosphorylation and inhibition of glycogen synthase kinase 3 (GSK-3), which appears to play a role in the regulation of the cell cycle and activation of transcription factors such as AP-1 and b-catenin-Lef-1/ Tcf (Troussard et al., 1999; Novak et al., 1998) .
Because activation of the PKB/Akt pathway has been demonstrated to suppress apoptosis and anoikis in epithelial cells (both by PI3-kinase activation and PTEN inactivation) (Khwaja et al., 1997; Stambolic et al., 1998; Liu et al., 1999) , and because ILK provides a potential direct link between integrins and this pathway, we investigated the role of ILK in the suppression of anoikis in SCP2 mouse mammary epithelial cells.
As shown in Figure 1a , ILK activity is stimulated in SCP2 mouse mammary epithelial cells upon attachment to the extracellular matrix protein ®bronectin, but not when the cells are plated on poly-HEMA, a substrate to which cells cannot adhere. This suggested that if ILK is overexpressed, it may protect cells from apoptosis in suspension. SCP2 cell lines stably transfected with ILK in the sense (SCP2 ± ILK13) or antisense (SCP2-14) orientation were established previously (Novak et al., 1998) , and it has been shown that the level of ILK protein in the SCP2 ± ILK13 cells is high, while that of the SCP2-14 cells is extremely low. As shown in Figure 1b , the control SCP2-14 cells are highly sensitive to anoikis when kept in suspension by plating on poly-HEMA. The parental SCP2 cells were also similarly sensitive to anoikis under these conditions (data not shown). However, anoikis is markedly inhibited in the ILK-overexpressing SCP2 ± ILK13 cells. This inhibition is reversed by transfection and expression of a dominant-negative form of ILK (ILK KD) or a dominant negative PKB (PKB AAA), but not by transfection of GSK-3. This indicates that ILK inhibits anoikis through its activation of the PKB pathway, and not through its inhibition of GSK-3. Focal adhesion kinase (FAK) has also been implicated as a possible regulator of anoikis, as its activity is also stimulated by integrin ligation and it has been reported to activate the PKB pathway through an unknown mechanism (Frisch et al., 1996b; Khwaja et al., 1997) . However, a dominant negative form of FAK (FRNK) (Zhao et al., 1998) was unable to reverse the ability of ILK to suppress anoikis, suggesting that these two kinases act independently. Because the transient transfection eciency of SCP2 cells is only approximately 20%, the cells were co-transfected with green uorescent protein (GFP) in a 1 : 10 ratio, to select for a b Figure 1 ILK activity is substrate dependent and ILK suppresses anoikis in a PKB/Akt-dependent manner. (a) ILK activity increases upon adhesion to ®bronectin, but not poly-HEMA. Kinase assays performed as described previously (Troussard et al., 1999) , and were analysed by densitometry. (b) SCP2-14 and SCP2 ILK13 cells (10 6 ) were transfected with 2 mg of either empty pcDNA3:His vector, ILK KD:V5, PKB AAA:HA, GSK-3:HA or FRNK:HA and 0.2 mg of GFP, using 3 ml of Fugene 6 transfection reagent (Boehringer Mannheim). Cells were grown in DMEM F-12 with 5% serum and 5 mg/ml insulin for 48 h, and then plated on either Fibronectin (FN) or poly-HEMA coated plates with 0.5% serum for 10 h. Cells were then harvested and stained with annexin-V PE (Pharmingen) according to manufacturer's instructions. Cells were analysed on a Coulter EXPO XL4¯ow cytometer under FL1 and FL2 channels. Figure 2 . The control SCP2-14 cells display low levels of Ser-473 phosphorylation and activity, and these are both increased in the ILKoverexpressing SCP2 ± ILK13 cells. When the SPC2 ± ILK13 cells are transfected transiently with ILK KD or PKB AAA, decreases in Ser-473 phosphorylation and kinase activity are observed, consistent with the 20% transfection eciency. As expected, GSK-3 transfection fails to reverse PKB/Akt Ser-473 phosphorylation and activation in SCP2 ± ILK13 cells.
Next, we looked at the activation of downstream factors involved in apoptosis. As mentioned above, PKB/Akt inhibits apoptosis through several pathways, resulting in the downstream inhibition of the processing and activation of caspases. Thus, we ®rst examined the activation of the inducer caspase, caspase-8. As shown in Figure 3a , signi®cant processing of caspase-8 is observed in the control SCP2-14 cells, resulting in detection of the active 18 kDa fragment (Figure 3) . The extent of this processing is signi®cantly lower in the ILK-overexpressing SCP2 ± ILK13 cells, indicating an inhibition of anoikis. The transfection of ILK KD and PKB AAA resulted in a slight increase in the amount of caspase-8 processing, again consistent with a 20% transfection eciency. Because caspase-8 is capable of directly cleaving and activating the executioner caspase-3, resulting in a 17 kDa fragment (Dragovich et al., 1998), we examined this next. Like caspase-8, caspase-3 is cleaved in the SCP2-14 cells, but this cleavage is inhibited in the Figure 2 ILK induces PKB/Akt Ser-473 phosphorylation and activity. Cells were plated on poly-HEMA coated plates as above, and lysed using cell lysis buer (New England Biolabs) according to manufacturer's instructions. Western blot analysis using anti PKB/Akt Ser-473-P and anti PKB/Akt (New England Biolabs) were carried out as described (Delcommenne et al., 1998) . PKB/ Akt kinase assay performed using the Akt kinase assay kit (New England Biolabs) according to manufacturer's instructions a b Figure 3 ILK inhibits the activation of Caspase-8 and Caspase-3. (a) Western blot analyses carried out as described (Delcommenne et al., 1998) . Antibodies used were the following: rabbit polyclonal anti cleaved caspase-8 (Calbiochem) and rabbit polyclonal anti caspase-3 (Upstate Biotechnology). (b) Cells (2610 6 ) were grown in full serum for 24 h, with or without 10 mm of KP-SD1, and then were plated on Fibronectin or Poly-HEMA, with no serum, for 8 h. ApoAlert TM CPP32/Caspase-3 Assay Kit (Clontech) was used according to manufacturer's instructions SCP2 ± ILK13 cells. Transfection of the ILK KD and PKB AAA, but not GSK-3, results in the reversal of this inhibition. These results are supported by Figure  3b , which shows caspase-3-like activity, based on its ability to cleave a colorimetric substrate, DEVD-pNA. Caspase-3-like activity is dramatically inhibited in the ILK-overexpressing cells, but this inhibition is reversed upon the addition of a highly selective, small molecule ILK inhibitor KP-SD1 (Persad et al., 2000; Sanghera et al., submitted) . The low level of caspase-3-like activity in the cells plated on ®bronectin demonstrates that KP-SD1 is not merely toxic, but has a speci®c eect on anoikis.
SCP2 cells are normal, untransformed mammary epithelial cells, and thus do not have high basal levels of ILK activity, and are sensitive to anoikis (Novak et al., 1998) . However, many transformed epithelial cell lines are resistant to anoikis, possibly due to an increase in ILK activity. To test this, we examined the ability of a dominant negative ILK, or the ILK inhibitor KP-SD1, to induce anoikis in the breast cancer cell lines MDA 231 and MDA 453. As shown in Figure 4a , transfection and expression of ILK KD induces a high level of anoikis in MDA 453 cells, and an intermediate level in MDA 231 cells, consistent with the relative transfection eciencies of the two cell lines (60% for MDA 453, 40% for MDA 231). Exposure of the two cell lines to the inhibitor KP-SD1 also induced a signi®cant level of anoikis. Dierent levels of sensitivity in the two cell lines may be due to diering characteristics such as membrane permeability. These results are further supported by Figure 4b , which measures anoikis by annexin-V binding in the MDA 453 cells. In both cases, inhibition of ILK activity induced anoikis compared to control treated cells. These data demonstrate that the inhibition of ILK sensitizes human breast cancer cell lines to anoikis, implicating ILK as a major regulator of anoikis.
It has been reported that anoikis involves the activation of caspase-8 and the Fas-associated death domain (FADD) protein (Ryotomaa et al., 1999; Frisch, 1999) . However, it was not clear whether death receptor signalling was necessary for the activation of this pathway, and thus it was unknown what factors initiated the caspase cascade. It is possible that integrin and death receptor signalling cooperate to regulate anoikis through an as yet unknown mechanism. It is however, highly likely that factors capable of communicating directly with integrins are crucial in anoikis regulation, as cell detachment is the initiating event in anoikis. Together, the data shown here suggest a model in which attached mammary cells signal through ILK to activate the PKB/Akt signalling cascade, resulting in the inhibition of downstream caspase activation. When normal cells are detached the ILK/PKB/Akt pathway is turned o, resulting in the activation of the caspase signalling cascade. However, if ILK becomes constitutively active due to oncogenic transformation, anoikis may be inhibited when cells are detached, resulting in metastatic growth. Thus, ILK inhibition may be an eective means of breast cancer therapy, as it may prevent metastasis through anoikis induction. ) were transfected with either pcDNA3:His or ILK KD:V5 vector with 4 ml lipofectin, and grown in DMEM F-12 with 5% serum for 48 h. Cells were treated with 100 mm KP-SD1 for 24 h. All cells were plated on poly-HEMA, in 0.5% serum, for 16 h, 72 h posttransfection. Cells were harvested and stained with trypan blue (Sigma), and counted on a VWR Levy hemacytometer. At least 600 cells from each set were counted. (b) MDA 453 cells were treated as in (a), and plated on either ®bronectin or poly-HEMA in 0.5% serum for 16 h. Cells were harvested and stained with annexin-V PE as in Figure 1 
